Most Download

Published in last 1 year | In last 2 years| In last 3 years| All| Most Downloaded in Recent Month | Most Downloaded in Recent Year|
All
Please wait a minute...
For Selected: Toggle Thumbnails
2022, 10 (4): 301-308. DOI: 10.3969/j.issn.2095-5332.2022.04.003
Abstract （300）      PDF （741KB）（934）      
2022, 10 (2): 146-146. DOI: 10.3969/j.issn.2095-5332.2022.02.010
Abstract （311）      PDF （684KB）（609）      
2022, 10 (4): 289-294. DOI: 10.3969/j.issn.2095-5332.2022.04.001
Abstract （216）      PDF （976KB）（593）      
2015, 3 (2): 74-78.
Abstract （49）      PDF （785KB）（345）      
Clinical efficacies of ABO-incompatible adult liver transplantation ：a report of 3 cases and review of the literature
QUMing, WANG Ying, SHI Yan-fen, DU Ying-dong, YIN Hui-sheng, LIU Yan-jun, ZHANG Cheng-jun.
2013, 1 (1): 31-34.
Abstract （120）      PDF （623KB）（325）      
Objective To summarize clinical efficacies of ABO-incompatible adult liver transplantation，review related literature，and explore correlated treatment strategy. Methods The clinical data of 3 patientsundergoing ABO-incompatible adult liver transplantation in our hospital from January 2008 to June 2011 wereanalyzed to summarize clinical efficacies of ABO-incompatible adult livertransplantation. Results All thepatients were recovered in 72 hours. Different extent of psychiatric symptoms occurred in 2 patients and recoveredafter olanzapine and haloperidol were given. Blood vessel and biliary duct complications had not occurred. Onepatient died of neoplasm metastasis. The other 2 were followed 1 year and 8 months respectively with good living status. Conclusion In the state of an illness threat to life，the ABO-incompatible adult liver transplantation is afeasible treatment strategy.
2022, 10 (4): 376-379. DOI: 10.3969/j.issn.2095-5332.2022.04.018
Abstract （131）      PDF （681KB）（309）      
2014, 2 (3): 177-178.
Abstract （39）      PDF （1179KB）（303）      
2015, 3 (2): 79-81.
Abstract （62）      PDF （641KB）（275）      
2020, 8 (3): 237-242. DOI: 10.3969/j.issn.2095-5332.2020.03.019
Abstract （86）      PDF （747KB）（269）      
2018, 6 (6): 486-488. DOI: 10.3969/j.issn.2095-5332.2018.06.021
Abstract （94）      PDF （2008KB）（248）      
2022, 10 (2): 183-188. DOI: 10.3969/j.issn.2095-5332.2022.02.019
Abstract （85）      PDF （720KB）（246）      
2015, 3 (2): 125-128.
Abstract （45）      PDF （742KB）（244）      
2018, 6 (5): 385-. DOI: 10.3969/j.issn.2095-5332.2018.05.010
Abstract （180）      PDF （947KB）（240）      
2015, 3 (6): 321-327.
Abstract （76）      PDF （3342KB）（239）      
2020, 8 (5): 337-341. DOI: 10.3969/j.issn.2095-5332.2020.05.003
Abstract （135）      PDF （2013KB）（220）      
2014, 2 (3): 141-146.
Abstract （78）      PDF （3039KB）（212）      
2020, 8 (4): 300-303. DOI: 10.3969/j.issn.2095-5332.2020.04.018
Abstract （65）      PDF （794KB）（207）      
2016, 4 (1): 54-56.
Abstract （47）      PDF （2274KB）（200）      

The report of two cases of gene mutation detection and immune microenvironment detection of hepatic carcinoma 

Deng Wen, Li Jiahao, Du Ying.
2022, 10 (3): 226-232. DOI: 10.3969/j.issn.2095-5332.2022.03.007
Abstract （161）      PDF （1070KB）（198）      

Objective Gene detection and immune microenvironment detection in liver cancer can guideanti-tumor therapy，but there are few studies on gene detection and microenvironment detection in liver cancer. In this study，we reported the results of two cases of hepatic carcinoma，one is hepatocellular carcinoma and the other is intrahepatic cholangiocarcinoma，and provided preliminary insightsfor the treatment of hepatic carcinoma in the future. Methods In this study，thetumorspecimensoftwopatientsweretestedby multipleximmunohistochemistry/immunofluorescence techniques and tumor gene sequencing. Both patients were under follow- up observation. Results Both patients were belonged to immune non-response type. The overall results showed that the effect of single drug immunotherapy may not be ideal. Partial gene detection results suggested that immune checkpoint blockade may be effective for both patients . Neither patient received immunotherapy. Conclusion The results of these two patients suggested that the effect of immunotherapy is not satisfactory. But immunotherapy is a promisingtreatment for cancerat present, and combinedimmunotherapy maybe helpful for liver cancer. 

2014, 2 (3): 179-180.
Abstract （66）      PDF （1218KB）（197）      
Practical Journal of Organ Transplantation(Electronic Version)
The system is developed by Beijing magtech Technology Co., Ltd. Support@magtech.com.cn